Key facts
- MDSIM’s last known valuation is $11.3M (Jun 2025).
- It has raised $5.9M; the latest was Seed Round ($2.6M) in Jun 2025.
- Notable investors include Fit 4 Start, Astorg, Kadmos Capital, Luxinnovation, Technoport.
- Status: Privately Held (backing).
- ·The complete investor list — 5 names
- ·Watchlist + deal alerts for MDSIM
- ·The full record, as it builds
Funding rounds
No funding rounds for MDSIM are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About MDSIM
Developer of a medical simulation platform designed to help medical device companies and surgeons develop and use optimal medical products for better patient care. The company's software is made using computer modeling and simulation (CMS) combined with data sciences and AI, enabling healthcare institutions to improve the quality of life of patients around the globe.
- Sector
- Healthcare
- HQ
- Esch-sur-Alzette, Luxembourg
- Founded
- 2022
- Employees
- 9
- Website
- mdsim.health/
- Ownership
- Privately Held (backing)
MDSIM doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in MDSIM shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on MDSIM in its N-PORT filings yet. We sweep new filings monthly.